NCT04309253View on ClinicalTrials.gov

The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

May 18, 2024

Study Completion Date

November 30, 2025

Conditions
Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia
Interventions
DRUG

PMPBB3

F-18 PMPBB3 PET Imaging

DRUG

AV45

F-18 AV45 PET Imaging

Trial Locations (1)

333

RECRUITING

Department of Neurology, Chang-Gung memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER